Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-642-6 | CAS number: 85-91-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Reproductive toxicity study
Based on the data available from different studies, NOAEL was considered to be 244 mg/kg body weight/day for male and 288 mg/kg bw for female when CFE male and female rat treated with test material orally,Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Link to relevant study records
- Endpoint:
- toxicity to reproduction
- Remarks:
- other: Chronic repeated dose toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer- reviewed journal
- Qualifier:
- according to guideline
- Guideline:
- other: as below
- Principles of method if other than guideline:
- Chronic repeated dose toxicity study of tets material in rats.
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- other: CFE
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF colony
- Age at study initiation: (P) x wks; (F1) x wks: No data available
- Weight at study initiation: (P) Males: x-x g; Females: x-x g; (F1) Males: x-x g; Females: x-x g: No data available
- Fasting period before study: No data available
- Housing: Animals were housed 5 rat per cage
- Diet (e.g. ad libitum): Spillers' Laboratory Small Animal Diet, ad libitum
- Water (e.g. ad libitum): Water, ad libitum
- Acclimation period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data available
- Humidity (%): No data available
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): No data available
IN-LIFE DATES: From: To: No data available - Route of administration:
- oral: feed
- Vehicle:
- other: Spillers' Laboratory Small Animal Diet
- Details on exposure:
- No data available
- Details on mating procedure:
- No data available
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- By using Pye 104 dual flame ionization chromatograph.
- Duration of treatment / exposure:
- 90 days
- Frequency of treatment:
- Daily
- Details on study schedule:
- No data available
- Remarks:
- Doses / Concentrations:
0, 300, 1200 and 3600 ppm (21, 82 and 244 mg/kg/day for the three dose levels in males and 24, 95 and 280 mg/kg/ day in females.)
Basis:
actual ingested - No. of animals per sex per dose:
- Total: 120
0 ppm : 15 male, 15 female
300 ppm : 15 male, 15 female
1200 ppm : 15 male, 15 female
3600 ppm : 15 male, 15 female - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Because of the small amount of flavoring lost from the test diets and its apparent palatability, the material was administered in the diet at 0, 300, 1200 and 3600 ppm
- Positive control:
- No data available
- Parental animals: Observations and examinations:
- Clinical sign, Body Weight, Food consumption, Water Consumption, Haematology, Clinical Chemistry and Urinalysis were observed .
- Oestrous cyclicity (parental animals):
- No data available
- Sperm parameters (parental animals):
- No data available
- Litter observations:
- No data available
- Postmortem examinations (parental animals):
- Reporductive organ weight, gross pathology and histopathology were exmined.
- Postmortem examinations (offspring):
- No data available
- Statistics:
- Statistical analysis is performed by using Student's t test for the significance of Haematological examination and Absolute and relative organ weights.
- Reproductive indices:
- No data available
- Offspring viability indices:
- No data available
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- no effects observed
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- not specified
- Dose descriptor:
- NOAEL
- Effect level:
- 244 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: No effect on reporductive organweight, gorss pathology and histopathology
- Remarks on result:
- other: No effect on reporductive organ weight
- Dose descriptor:
- NOAEL
- Effect level:
- 288 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: No effect on reporductive organ weight, gorss pathology and histopathology
- Remarks on result:
- other: No effect on reporductive organ weight
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Other effects:
- not specified
- Behaviour (functional findings):
- not specified
- Developmental immunotoxicity:
- not specified
- Dose descriptor:
- other: not specified
- Generation:
- other: not specified
- Based on:
- not specified
- Sex:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- not measured/tested
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Relation to other toxic effects:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
- Conclusions:
- NOAEL was considered to be 244 mg/kg body weight/day for male and 288 mg/kg bw for female when CFE male and female rat treated with test material orally.
- Executive summary:
In a Chronic repeated dose toxicity study, CFE male and female rat were treated with test material in the concentration of 0, 300, 1200 and 3600 ppm orally in diet equivalant to average intakes of 21, 82 and 244 mg/kg/day for males and 24, 95 and 280 mg/kg/ day for females.No signs of ill health, change in body weight,food and water consumption, Clinical chemistry and Urinanalysis were observed in treated male and female rat during the study as compared to control. At 6 week, significant decrease was observed in hemoglobin, RBC and WBC (particularly the lymphocytes) of male and female rat when treated with 82 and 244 mg/kg bw and 82 and 96 mg/kg bw treated rats. Similarly, Absolute and relative kidney weight was significantly increased in male rat and absolute and relative kidney weight , relative adrenals and ovaries weight in female when treated with 82 and 244 mg/kg bw and 82 and 96 mg/kg bw treated rats as compared to control. As no effect on reproductive oragn weight of female gonads were observed in 288 mg/kg bw, the observed change in relative organ weight of female gonads were considered to be non significant. In addition,No gross abnormalities and histopathological changes were observed in Gonads of treated male and female rat as compared to control.Therefore, NOAEL was considered to be 244 mg/kg body weight/day for male and 288 mg/kg bw for female when CFE male and female rat treated with test material orally in feed for 90 days.
Reference
Clinical signs:No signs of ill health were observed in treated rat during the study as compared to control.
Body weight: No effect was observed on body weight and weight gain of treated rat as compared to control.
Food consumption: No effect was observed on food consumption of treated rat as compared to control.
Test substance intake:Average intakes of were 21, 82 and 244 mg/kg/day for the three dose levels in males and 24, 95 and 280 mg/kg/ day in females.
Organ weights: When male and female rats treated with 244 and 280 mg/kg bw, Absolute and relative kidney weight was significantly increased in male and relative weight in female as compared to control.
When male and female rats treated with 82 and 95 mg/kg bw, Absolute and relative kidney weight was significantly increased in male and relative kidney, adrenals and ovaries weight in female as compared to control.
No effect on reproductive oragn weight of female gonads were observed at 288 mg/kg bw.
Gross pathology: No gross abnormalities were observed in Gonads of treated male and female rat as compared to control.
Histopathology: No histopathological changes were observed in Gonads of treated male and female rat as compared to control.
other findings:
Water consumption: No effect was observed on water consumption of treated rat as compared to control.
Haematology:
At 6 week,
When treated with 244 and 280 mg/kg bw, in male rat significant decrease were observed in hemoglobin, RBC and WBC (particularly the lymphocytes) and in female significant decrease hemoglobin were observed.
When treated with 82 and 96 mg/kg bw, in male rat significant decrease were observed in WBC (particularly the lymphocytes) and in female hemoglobin level as compared to control.
At autopsy,
No significant differences between treated and control groups were observed.
Clinical chemistry:No significant differences were observed in treated rat as compared to control.
Urinanalysis: No significant differences were observed in urine analyses of treated rat as compared to control.
Absolute and relative organ weights of rats fed at 0-3600 ppm of the diet for 13 wk
Sex and dietary level (ppm) |
Organ weights |
Terminal body weight (g) |
|||||||||||
Brain |
Heart |
Liver |
Spleen |
Stomach |
Intestine |
Caecum |
Kidneys |
Adrenalst |
Gonads |
Pituitaryt |
Thyroid |
||
Male |
Absolute organ weight (g) |
||||||||||||
0 |
1.88 |
1.29 |
10.31 |
0.75 |
1.52 |
5.67 |
1.07 |
2.79 |
55 |
3.62 |
12 |
22 |
415 |
300 |
1.87 |
1.31 |
10.24 |
0.72 |
1.52 |
5.96 |
1.09 |
2.92 |
52 |
3.53 |
12 |
22 |
420 |
1200 |
1.85 |
1.30 |
10.49 |
0.77 |
1.50 |
5.84 |
1.01 |
2.97** |
54 |
3.57 |
12 |
23 |
42 |
3600 |
1"86 |
1-28 |
10.57 |
0'75 |
1.56 |
5.76 |
1.16 |
3.04** |
53 |
3.47 |
12 |
22 |
414 |
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
1.76 |
0.96 |
0.62 |
1.38 |
5.43 |
0.89 |
0.89 |
1.83 |
61 |
0.13 |
15 |
19 |
286 |
300 |
1.74 |
0.93 |
6.35 |
0-58 |
1.36 |
5.60 |
0.92 |
1.85 |
62 |
0.14 |
15 |
19 |
283 |
1200 |
1.76 |
0.93 |
6.25 |
0.60 |
1.32 |
5.34 |
0.89 |
1.88 |
66 |
0.15 |
15 |
20 |
27 |
3600 |
1.87 |
0.93 |
6.58 |
0.59 |
1.33 |
5.66 |
0.94 |
1.91 |
64 |
0.13 |
16 |
19 |
282 |
Male |
Relative organ weight (g/100 g body weight |
||||||||||||
0 |
0.45 |
0.31 |
2.50 |
0.18 |
0.37 |
1.37 |
0.25 |
0.67 |
13.2 |
0.87 |
2.82 |
5.26 |
|
300 |
0.44 |
0.31 |
2.44 |
0.17 |
0.36 |
1.42 |
0.25 |
0.69 |
12.4 |
0.84 |
2.85 |
5.22 |
|
1200 |
0.44 |
0.31 |
2.47 |
0.18 |
0.35 |
1.38 |
0.23 |
0.70* |
12.8 |
0.84 |
2.82 |
5.52 |
|
3600 |
0.45 |
0.31 |
2.57 |
0.18 |
0.38 |
1.39 |
0.28 |
0.73*** |
12.8 |
0.84 |
2.77 |
4.99 |
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
0.62 |
0.33 |
2.40 |
0.21 |
0.48 |
1.89 |
0.32 |
0.64 |
21.6 |
0.045 |
5.17 |
6.62 |
|
300 |
0.62 |
0.33 |
2.37 |
0.21 |
0.48 |
1.97 |
0.32 |
0.66 |
21.8 |
0.048 |
5.23 |
6.56 |
|
1200 |
0.64 |
0.34 |
2.42 |
0.22 |
0.48 |
1.94 |
0.32 |
0.69** |
24.1'* |
0.052* |
5.53 |
7.10 |
|
3600 |
0.63 |
0.33 |
2.47 |
0.21 |
0.47 |
2.00 |
0.33 |
0.68* |
22.7 |
0.046 |
5.68 |
6.56 |
|
ϮValues of absolute and relative weights of this organ are expressed in mg and mg[100 g body weight respectively.
Values are the means of groups of 15 animals and those marked with asterisks differ significantly (Student'sttest) from those of controls: *P < 0"05; **P < 0"01; ***P < 0"001.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 244 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Data is Klimicsh 2 and from authoritative database
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Reproductive toxicity study
Data available from different studies were reviewed to determine the reproductive toxicity of test chemical.The studies are as mentioned below:
Study 1
In a Chronic repeated dose toxicity study, CFE male and female rat were treated with test material in the concentration of 0, 300, 1200 and 3600 ppm orally in diet equivalant to average intakes of 21, 82 and 244 mg/kg/day for males and 24, 95 and 280 mg/kg/ day for females.No signs of ill health, change in body weight,food and water consumption, Clinical chemistry and Urinanalysis were observed in treated male and female rat during the study as compared to control. At 6 week, significant decrease was observed in hemoglobin, RBC and WBC (particularly the lymphocytes) of male and female rat when treated with 82 and 244 mg/kg bw and 82 and 96 mg/kg bw treated rats. Similarly, Absolute and relative kidney weight was significantly increased in male rat and absolute and relative kidney weight , relative adrenals and ovaries weight in female when treated with 82 and 244 mg/kg bw and 82 and 96 mg/kg bw treated rats as compared to control. As no effect on reproductive oragn weight of female gonads were observed in 288 mg/kg bw, the observed change in relative organ weight of female gonads were considered to be non significant. In addition,No gross abnormalities and histopathological changes were observed in Gonads of treated male and female rat as compared to control.Therefore, NOAEL was considered to be 244 mg/kg body weight/day for male and 288 mg/kg bw for female when CFE male and female rat treated with test material orally in feed for 90 days.
Study 2
Combined repeated dose repro-developmental toxicity study was to provide evaluations of general and reproduction/ developmental toxicity endpoints associated with administration of repeated doses of test material in Wistar rats. The animals were randomly allocated to the four main groups (13/sex/group) and two recovery groups (5/sex/group). The doses selected for main groups were; 0 (G1-control),308 mg/kg body weight (G2), 556 mg/kg body weight (G3) and 1000 mg/kg body weight (G4) daily for 64 days. The recovery groups G1-R and G4-R were dosed with similar doses of respective main groups.Vehicle corn oil to G1 and G1-R and test item to G2, G3, G4 and G4-R animals were administered by oral gavage route each day during the dosing period. No mortality and morbidity were observed any of the groups of animals throughout the study period. Animals of all dose groups were observed for Clinical signs/ symptoms daily once during the experimental period. No apparent treatment related clinical signs were observed in any of the animals throughout the treatment and recovery period. Detailed clinical examinations like Home cage observation, Handling observation and Open field observation of all animals were observed to be normal during study period. Number of rear, urine pools, fecal bolus in animals of all the test groups of both the sexes was comparable and did not show any treatment related significant difference as compared to the respective control groups. Body weight, percent body weight changes and feed consumption in animals of all the test groups of both the sexes was comparable and did not show any treatment related significant difference as compared to the respective control groups. The sensory reactivity measurements were comparable and no statistically significant changes were revealed in animals of treatment groups in both the sexes. Foot splay and fore limb and hind limb grip strength parameters were comparable and no treatment related changes were revealed in any of the animals of all treated groups as compare to the repective control groups. Motor activity measurements were comparable and no changes were revealed in any of the animals of all treated groups of both the sexes as compared to control group. Estrous cycle was evaluated for checking the regularity during treatment period and in cohabitation for confirmation of pregnancy.
No test item related changes in estrous cyclicity and precoital interval were observed. There was statistically significant decrease in G3 (556 mg/kg body weight) as compared to control G1 (0 mg/kg body weight). This is not dose dependent hence not considered as treatment related. There was no statistically significant difference between the control and treatment groups in the maternal and pups parameters, except markedly decreased pregnancy index / fertility index in G4 (1000 mg/kg body weight), which was considered to be treatment related. All hematological and clinical chemistry parameters in animals of different treated groups of both the sexes were comparable to their respective control groups. No treatment related changes were observed in any of the treatment groups. At the end of treatment and recovery period, absolute and relative weight of organs of treated group rats of either sex did not differ significantly when compared to the respective control group rats. External and visceral examination of all male and female rats of control and all treated groups including recovery groups did not reveal any abnormality of pathological significance. Terminally sacrificed pups of all treated groups did not reveal any lesion of pathological significance in any of the group when compared with control group. Pups that died among the control and treated groups during the course of study, revealed various lesions when examined externally and internally but the observations were not considered treatment related. From the patho-morphological results presented, it is concluded that, the treatment of Methyl Phenyl acetate at 308, 556 and 1000 mg/kg body weight in male and female rats did not affect adversely and no alteration of pathological significance was observed in any of the organs including reproductive organs. Lesions observed in liver, kidneys, lungs, heart, aorta, stomach, lymph nodes, spleen, thymus, trachea, adrenal gland and reproductive organs of high dose treated group rats are well comparable with respective control group rats and exhibited no dose relationship. Further these observed lesions are common in occurrence in rodents during toxicological studies. Hence, occurrence of these lesions could be considered as spontaneous or incidental in nature and not to be attributed to the administration of the Test Item.
Based on the findings of Repeated Dose Oral Toxicity Study in combination with Reproduction/ Developmental Toxicity of test material in Wistar Rats with 14 days recovery, where in 0, 308, 556 and 1000 mg/kg body weight, doses were tested;No Observed Adverse Effect Level (NOAEL) is considered to be 556 mg/kg bw. When male and female wistar rats were treated with test material orally.
Based on the data available from different studies ,test material did not showedreproductive toxicityat dose concentration 244 mg/kg body weight/day for male and 288 mg/kg bw for female, when CFE male and female rat treated with test material orally,Thus, comparing this value with the criteria ofCLP regulationtest materialis not likely to classify as reproductive toxicant.
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Thus, comparing this value with the criteria of CLP regulation test material is not likely to classify as reproductive toxicant.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.